Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals posted Q1 2026 adjusted EPS of $0.01, beating consensus estimate of -$0.04 by $0.05. Revenue rose 73% YoY to $15.11 million, surpassing the $14.65 million forecast, driven by PE